Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
This week, the Ministry of Health of Ukraine, the Verkhovna Rada Committee on National Health, and leading members of associations representing the interests of the pharmaceutical and pharmacy industries signed…